542 related articles for article (PubMed ID: 33563834)
1. Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections.
Santi I; Manfredi P; Maffei E; Egli A; Jenal U
mBio; 2021 Feb; 12(1):. PubMed ID: 33563834
[TBL] [Abstract][Full Text] [Related]
2. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
[TBL] [Abstract][Full Text] [Related]
3. The Use of Experimental Evolution to Study the Response of Pseudomonas aeruginosa to Single or Double Antibiotic Treatment.
Santi I; Manfredi P; Jenal U
Methods Mol Biol; 2021; 2357():177-194. PubMed ID: 34590259
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution.
Botelho J; Grosso F; Peixe L
Drug Resist Updat; 2019 May; 44():100640. PubMed ID: 31492517
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic Resistance in Pseudomonas.
Laborda P; Hernando-Amado S; Martínez JL; Sanz-García F
Adv Exp Med Biol; 2022; 1386():117-143. PubMed ID: 36258071
[TBL] [Abstract][Full Text] [Related]
6. Variation in the response to antibiotics and life-history across the major
Tueffers L; Batra A; Zimmermann J; Botelho J; Buchholz F; Liao J; Mendoza Mejía N; Munder A; Klockgether J; Tüemmler B; Rupp J; Schulenburg H
Microbiol Spectr; 2024 Jul; 12(7):e0014324. PubMed ID: 38860784
[TBL] [Abstract][Full Text] [Related]
7. Changes in antibiotic resistance in recurrent Pseudomonas aeruginosa infections of chronic suppurative otitis media.
Song JJ; Lee BD; Lee KH; Lee JD; Park YJ; Park MK
Ear Nose Throat J; 2016; 95(10-11):446-451. PubMed ID: 27792822
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.
El Zowalaty ME; Al Thani AA; Webster TJ; El Zowalaty AE; Schweizer HP; Nasrallah GK; Marei HE; Ashour HM
Future Microbiol; 2015; 10(10):1683-706. PubMed ID: 26439366
[TBL] [Abstract][Full Text] [Related]
9. Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa.
Laborda P; Martínez JL; Hernando-Amado S
Microbiol Spectr; 2022 Aug; 10(4):e0024722. PubMed ID: 35766499
[TBL] [Abstract][Full Text] [Related]
10. TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.
Xia Y; Wang D; Pan X; Xia B; Weng Y; Long Y; Ren H; Zhou J; Jin Y; Bai F; Cheng Z; Jin S; Wu W
mBio; 2020 Jan; 11(1):. PubMed ID: 31911486
[TBL] [Abstract][Full Text] [Related]
11. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
Lodise TP; Miller CD; Graves J; Furuno JP; McGregor JC; Lomaestro B; Graffunder E; McNutt LA
Antimicrob Agents Chemother; 2007 Feb; 51(2):417-22. PubMed ID: 17158943
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
Pang Z; Raudonis R; Glick BR; Lin TJ; Cheng Z
Biotechnol Adv; 2019; 37(1):177-192. PubMed ID: 30500353
[TBL] [Abstract][Full Text] [Related]
14. Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance.
Cohen MJ; Block CS; Moses AE; Nir-Paz R
Clin Microbiol Infect; 2014 Mar; 20(3):O188-96. PubMed ID: 24102767
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
[TBL] [Abstract][Full Text] [Related]
17. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G
Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.
Ruiz-Garbajosa P; Cantón R
Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():8-12. PubMed ID: 28882007
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.
Lamers RP; Burrows LL
Future Med Chem; 2016 Jun; 8(9):975-92. PubMed ID: 27228070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
